DRW Securities’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-158,100
Closed -$26.2M 1190
2025
Q1
$26.2M Buy
+158,100
New +$24.7M 0.73% 27
2024
Q3
Sell
-1,700
Closed -$249K 645
2024
Q2
$249K Buy
1,700
+200
+13% +$29.7K 0.01% 432
2024
Q1
$237K Buy
+1,500
New +$239K 0.01% 315
2023
Q2
Sell
-22,300
Closed -$3.46M 400
2023
Q1
$3.46M Buy
22,300
+17,200
+337% +$2.78M 0.06% 79
2022
Q4
$901K Sell
5,100
-41,100
-89% -$7.1M 0.02% 126
2022
Q3
$7.55M Buy
46,200
+27,500
+147% +$4.65M 0.16% 46
2022
Q2
$3.32M Buy
18,700
+6,500
+53% +$1.16M 0.08% 65
2022
Q1
$2.16M Buy
12,200
+8,300
+213% +$1.41M 0.06% 90
2021
Q4
$667K Sell
3,900
-1,900
-33% -$311K 0.02% 116
2021
Q3
$937K Sell
5,800
-3,300
-36% -$563K 0.04% 111
2021
Q2
$1.5M Buy
+9,100
New +$1.51M 0.05% 100

Other funds holding JNJ

DRW Securities's JNJ Position: Q2 2026 in Review

DRW Securities sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 8,867 shares — an estimated $2.16M sold.

DRW Securities first reported a position in JNJ in Q3 2016 and held it in 19 quarters. The position peaked at $5.53M in Q1 2025. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • DRW Securities reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • DRW Securities sold 8,867 Johnson & Johnson shares in Q2 2026, an estimated $2.16M.
  • DRW Securities first reported a position in Johnson & Johnson in Q3 2016 and held it in 19 quarters.
  • DRW Securities's Johnson & Johnson position peaked at $5.53M in Q1 2025.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.